Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma

Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy

The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore

New Gastrointestinal Pathogen Assays Available from ALPCO

New Gastrointestinal Pathogen Assays Available from ALPCO

ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO

NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Pharma

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis

Thrivous Announces Science Advisor Board

Thrivous, a human intelligence and vitality company, announces the formation of its science advisor board. The board will inform ongoing product and service development. Formation of the board reflects Thrivous' commitment to guidance from consensus science in its mission to help customers access... - October 28, 2016 - Thrivous

Thrivous Launches Serenity, the Nightly Nootropic

Thrivous, a human intelligence and vitality company, has developed and brought to market Serenity, the nightly nootropic. Serenity is designed for nightly use to promote calm and sleep, and to improve next-day focus. It is also designed to complement Clarity, the first nootropic brought to market... - October 28, 2016 - Thrivous

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC

Experimentica Ltd. Appoints New Director of In Vivo Pharmacology

Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd

Presentation from electroCore Shows That Healthcare Costs for Patients with a Primary Headache Diagnosis Cost Four Times More Than a Healthy Patient Due to Comorbidities

Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000. This... - October 22, 2016 - electroCore

Nerviano Medical Sciences Presents Data Regarding a Potent New Cytotoxic Molecule for ADC Generation

NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, hbighly suited to conjugation with targeted antibodies. - October 20, 2016 - NMS Group

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas

HyperFlux™ PRO Plus Now Available in Europe

Full Raman spectroscopy system joins Tornado Spectral Systems' stand-alone spectrometers. - October 14, 2016 - Tornado Spectral Systems

Oxford AHSN Recognizes the SGC with Its Annual Public-Private Collaboration Award

Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award. - October 11, 2016 - The SGC

Bioscience Americas Sponsors "Solutions for a Healthier World Foundation"

Independent not-for-profit will provide stem cell therapies for the less fortunate. - October 06, 2016 - Bioscience Americas

Stroke Patients Able to Walk Again After Stem Cell Therapy by Dr. Henderson at Regenerative Medical Group

Dr. Bryn J. Henderson and his Regenerative Medical Group can help stroke patients return to normal life as much as possible through advanced stem cell therapy. The touching story of Bill Dendiu, stroke survivor, who was able to walk again after innovative procedures at RMG gives hope to many patients. - October 06, 2016 - Regenerative Medical Group

Smart Wearables: The Future of Personalized Healthcare

Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of... - October 03, 2016 - Roots Analysis

Children with High Grade Brain Tumors Will Soon be Able to Receive Cutting Edge Oncolytic Virus Therapy

Re-engineered Polio Virus with Dramatic Response in Adults to be Made Available to Children in a Phase 1 Clinical Trial Jointly Funded by The Andrew McDonough B+ Foundation and Solving Kids’ Cancer. - September 30, 2016 - Solving Kids' Cancer

Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants

The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed

American Science and Technology Awarded Second New Patent

New Patented Process Can Produce High Quality Pulp as Well as Desirable Bio-Renewable Materials - September 29, 2016 - American Science and Technology

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN

Quorum Innovations Announces Availability of Human Microbiome Therapeutics to Treat Common Skin Conditions and Metabolic Disorders

Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders - September 24, 2016 - Quorum Innovations

Spaulding Clinical Research Named “Best Phase I Drug Development CRO”

International Life Sciences continue to have a global impact and be captivated by daily breakthroughs that focus on companies, departments, and individuals who truly deserve to be identified as unique in their industry. As such, Spaulding Clinical Research keeps conducting tests and research, embracing the most advanced technology to forge ahead into clinical research and biometric solutions. - September 24, 2016 - Spaulding Clinical Research, LLC

AUM LifeTech's Self-Delivering FANA Antisense Oligonucleotides to be Distributed by MoBiTec Germany

AUMsilence self-delivering oligos achieve highly efficient and potent antisense-based gene knockdown. No need to use toxic transfection reagents. Especially designed for primary cells and very difficult-to-transfect cell types. - September 24, 2016 - MoBiTec GmbH

For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany

TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH

MR Solutions to Supply Cryogen-Free 7T Simultaneous PET-MR Preclinical Imaging System for the Study of Alzheimer’s and Stroke at the University of Southern California

MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California... - September 22, 2016 - MR Solutions

Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus

Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO

Bioscience Americas Announces New Cellular Immunotherapy Treatment

Bioscience Americas Announces New Cellular Immunotherapy Treatment

The treatment represents a breakthrough therapy that incorporates advanced stem cell protocols. - September 20, 2016 - Bioscience Americas

HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression

Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in this area. With five commercialized products, the market has gained the... - September 19, 2016 - Roots Analysis

SE3D Awarded Phase Two NSF Grant

SE3D, a company leading innovation in bioscience education and technology, announced today that it has been awarded the Small Business and Innovation Research (SBIR) Phase II grant from the National Science Foundation (NSF). The NSF SBIR grant is awarded to organizations who create innovative... - September 16, 2016 - SE3D

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN

Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease

Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals

The Journal Headache Reports That electroCore’s Non-Invasive Vagus Nerve Stimulator is an Effective Bioelectric Medicine for Episodic Cluster Headache

In a multi-centered, sham-controlled study conducted in the United States, episodic cluster headache patients using the gammaCore non-invasive vagus nerve stimulation device (nVNS) had a significant and clinically meaningful benefit within 15 minutes of the treatment of the attack, as compared with... - September 14, 2016 - electroCore

CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017

1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute

The SGC Releases Enabling Information to Accelerate Drug Discovery

Data packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria. - September 13, 2016 - The SGC

Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate

Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a detailed study on the current market landscape, future trends and applications of these novel treatment options. - September 12, 2016 - Roots Analysis

CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research

The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH

Tornado Spectral Systems to Present and Exhibit at SciX 2016

Leading manufacturer of optical spectrometers and Raman spectroscopy systems to highlight innovative technologies at annual SciX conference. - September 08, 2016 - Tornado Spectral Systems

MR Solutions Accelerates Sales of Its Preclinical Multi-Modality, High Field, Cryogen Free Scanners

Simultaneous and sequential PET-MR imaging systems with proven reference sites on show at 2016 WMIC in New York. - September 08, 2016 - MR Solutions

Silicone Suction Hose from AdvantaPure(R) is Now NSF Listed; Provides an Increased Level of Quality Assurance

AdvantaPure’s APSW silicone suction hose now boasts an NSF listing (NSF-51), giving users reassurance for the product’s compatibility with food, beverage and other clean applications. APSW is reinforced with a helical stainless steel wire and layers of fabric and silicone to handle both suction and discharge applications. The hose is available in smooth or convoluted O.D. styles, withstands temperatures up to 350 degrees F, and may be sterilized using several different methods. - September 02, 2016 - AdvantaPure

Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH

Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH

NuvOx Pharma Awarded NIH Grant to Develop Technology to Treat Endocarditis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health for $243,164.00 entitled, “Fibrin Targeted Microbubbles and Ultrasound for... - August 27, 2016 - NuvOx Pharma

ÉlpisÉremo’s Breakthrough Technology to Transcend Stem Cell Regenerative Therapy

ÉlpisÉremo succeeds in the world’s first development of a revolutionary technology comparable to the “Med-Bay” seen in the movie "Elysium." - August 26, 2016 - Elpis Eremo Inc.

Clinical Trial Supplies

Clinical Trial Supplies

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged... - August 25, 2016 - Business Dialogue

PBTF Unites with We Can to Form California Chapter

The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation

FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke

Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Pharma

Press Releases 451 - 500 of 2,967